Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer
Clinical trial NCT01043484 · COMPLETED
Trial details
- NCT number
- NCT01043484
- Sponsor
- Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2013-01-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.